Funding stability SU2C operates with a revenue range of $25M-$50M and overall funding of $7M, indicating a solid donor base but room to expand corporate partnerships and grant opportunities to diversify funding streams.

Donor-first model 100% of donations support SU2C’s collaborative cancer research programs, signaling a strong trust cue for premium fundraising solutions, donor engagement platforms, and transparent impact reporting to enhance giving.

Technology adoption Utilize existing tech stack (Facebook Ads, Intercom, Klaviyo, Moz, Redshift, etc.) as a foundation to upsell advanced fundraising automation, digital marketing optimization, and data-driven donor segmentation services.

Collaborative research focus SU2C’s translational research mission presents opportunities to bundle partnerships with biotech startups, CROs, and academic consortia for sponsored studies, grant-writing support, and impact-focused program management tools.

Market positioning Position SU2C relative to peers with mid-sized revenue and mission-driven scale to target fundraising technology providers, donor experience vendors, and impact measurement platforms seeking nonprofit clients in the oncology space.